Savolitinib
In Stock•Starting at $26 for 1 mg•Purity ≥ 98%
| CAS No. | 1313725-88-0 |
|---|---|
| MDL No. | MFCD28359096 |
| MF | C17H15N9 |
| MW | 345.40 |
| InChI Key | XYDNMOZJKOGZLS-NSHDSACASA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 1 mg | 98% | $26 | In Stock | |
| 5 mg | 98% | $66 | In Stock | |
| 10 mg | 98% | $108 | In Stock | |
| 25 mg | 98% | $200 | In Stock | |
| 50 mg | 98% | $288 | In Stock |
Product Information
Savolitinib is a triazolopyrazine, specifically an 1H-[1,2,3]triazolo[4,5-b]pyrazine substituted at positions 1 and 6 with (1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl and 1-methyl-1H-pyrazol-4-yl groups, respectively. It is a highly selective MET tyrosine kinase inhibitor approved in China for advanced NSCLC with MET exon 14 skipping mutations. It functions as a c-Met tyrosine kinase inhibitor and antineoplastic agent, and belongs to the classes of pyrazoles, triazolopyrazines, and imidazopyridines.
| CAS No. | 1313725-88-0 |
|---|---|
| Product Name | Savolitinib |
Biological Targets
MET
Associated Conditions
urogenital neoplasm·carcinoma·rectum cancer·non-small cell lung carcinoma·cancer·
* The information provided here is compiled from public sources and is for reference only.